Zebra Capital Management LLC boosted its stake in Phibro Animal Health Corp (NASDAQ:PAHC) by 52.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,707 shares of the company’s stock after purchasing an additional 4,731 shares during the period. Zebra Capital Management LLC’s holdings in Phibro Animal Health were worth $292,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. increased its position in Phibro Animal Health by 2.9% in the 2nd quarter. Vanguard Group Inc. now owns 2,256,012 shares of the company’s stock valued at $71,673,000 after acquiring an additional 63,315 shares during the period. Fiduciary Management Inc. WI increased its position in Phibro Animal Health by 332.3% in the 2nd quarter. Fiduciary Management Inc. WI now owns 1,073,390 shares of the company’s stock valued at $34,102,000 after acquiring an additional 825,090 shares during the period. Janus Henderson Group PLC increased its position in Phibro Animal Health by 315.4% in the 2nd quarter. Janus Henderson Group PLC now owns 956,784 shares of the company’s stock valued at $30,397,000 after acquiring an additional 726,444 shares during the period. Foresters Investment Management Company Inc. increased its position in Phibro Animal Health by 2.3% in the 2nd quarter. Foresters Investment Management Company Inc. now owns 671,558 shares of the company’s stock valued at $21,335,000 after acquiring an additional 14,972 shares during the period. Finally, State Street Corp increased its position in Phibro Animal Health by 0.3% in the 3rd quarter. State Street Corp now owns 653,400 shares of the company’s stock valued at $13,937,000 after acquiring an additional 1,638 shares during the period. Hedge funds and other institutional investors own 49.94% of the company’s stock.
Shares of PAHC traded down $0.17 during trading hours on Friday, hitting $24.26. 50,641 shares of the stock were exchanged, compared to its average volume of 174,165. Phibro Animal Health Corp has a fifty-two week low of $20.00 and a fifty-two week high of $36.98. The company has a debt-to-equity ratio of 1.84, a current ratio of 3.21 and a quick ratio of 1.77. The business has a 50-day moving average of $22.87 and a 200-day moving average of $26.55. The firm has a market capitalization of $986.65 million, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 6.92 and a beta of 0.87.
Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.19 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.05). Phibro Animal Health had a return on equity of 25.52% and a net margin of 4.99%. The firm had revenue of $190.00 million for the quarter, compared to analyst estimates of $199.22 million. During the same quarter last year, the company earned $0.39 earnings per share. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. As a group, analysts forecast that Phibro Animal Health Corp will post 1.1 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.98%. The ex-dividend date of this dividend is Tuesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 31.37%.
Several equities analysts have issued reports on PAHC shares. Bank of America decreased their price target on shares of Phibro Animal Health from $29.00 to $18.00 and set an “underperform” rating for the company in a research report on Thursday, August 29th. TheStreet cut shares of Phibro Animal Health from a “b-” rating to a “c+” rating in a research report on Tuesday, September 10th. ValuEngine upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. BidaskClub upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Finally, Morgan Stanley upgraded shares of Phibro Animal Health from an “underweight” rating to an “equal” rating and upped their price target for the company from $21.00 to $30.00 in a research report on Thursday, September 5th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $26.60.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Featured Story: Call Option
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Phibro Animal Health and related companies with MarketBeat.com’s FREE daily email newsletter.